CLINICAL NUCLEAR MEDICINE, cilt.48, sa.11, ss.950-952, 2023 (SCI-Expanded)
Although distant cutaneous metastasis is an uncommon presentation of prostate cancer, it remains an important diagnostic consideration as an advanced disease and a poor prognosis. Herein we present a rare case of prostate cancer patient whose multiple cutaneous metastases were treated with Lu-177-PSMA-617 radioligand treatment. To our knowledge, it is the first report in which a complete response was seen with Ga-68-PSMA PET/CT scan after Lu-177-PSMA-617 radioligand treatment.